Enzalutamide adds 5 months survival in late-stage prostate cancer
Major clinical trial shows survival benefit
2012-08-16
(Press-News.org) Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer.
"This is a major advance. Not only do we see more survival benefit than from traditional chemotherapy, but the side effects of Enzalutamide are much lower. It provides both more benefit and less harm – you get the quantification of more life, but also see quality of life improvements," says study co-author, Thomas Flaig, MD, medical director of the University of Colorado Cancer Center's Clinical Investigations Shared Resource and associate professor of medicine at the University of Colorado School of Medicine.
The study, known by the acronym AFFIRM, followed 1199 patients with prostate cancer that had progressed despite both hormonal and chemotherapy treatments, with 2/3 of patients receiving the drug Enzalutamide versus control. Median overall survival for patients in the treatment arm of the trial was 18.4 months compared to 13.6 months for patients in the placebo arm. In addition to prolonged survival, patients given Enzalutamide showed meaningful improvement in other measures including PSA blood levels, an increase from 3.0 months to 8.3 months in time until PSA progression, and an increase from 2.9 months to 8.3 months in overall progression-free survival.
The once-a-day oral drug works by blocking prostate cancer's ability to supply itself with androgens – hormones including testosterone that otherwise drive the cancer's growth. It does this by binding to cancer cells' androgen receptors – the waving tentacles on the outsides of cells that are designed to grab specific molecules as they float past. Enzalutamide plugs these receptors, removing their ability to grab androgen.
This out-competition for space in androgen receptors is not a new strategy. But when treated with existing anti-androgen drugs, prostate cancer tends to pull androgen receptors inside the cell walls, into a cell's nucleus where the receptors are shielded from drugs but can continue to trap androgens and thus signal growth. In addition to plugging receptors, Enzalutamide inhibits this nuclear translocation.
"Prostate cancer has traditionally been viewed as having two phases," Flaig says, "first is the hormone-sensitive stage and second is the stage at which the disease is no longer dependent on hormones and we're forced to turn to more toxic chemotherapies." Even a few years ago, the use of a hormonal agent in this second phase of prostate cancer would have been viewed at futile. Beyond establishing a new treatment for advanced prostate cancer, this study also helps to redefine "hormone-refractory" prostate cancer and proves that androgen-targeted treatments continue to be relevant later into the disease process than previously believed.
"This approach represents a much more potent and effective means of targeting the androgen receptor than possible with previously available agents. While this study examined the effect of adding Enzalutamide to standard androgen deprivation therapy, future studies could explore a single agent approach with this drug to treat prostate cancer," Flaig says. Another major study to look at this pre-chemotherapy activity is underway.
"We are in a renaissance period in the medical therapy of prostate cancer," Flaig says. "Enzalutamide is a key member of a half dozen new and emerging drugs and the challenge of the next five years is to discover how to best time and potentially combine these new agents. But even at this early stage, Enzalutamide is a game changer."
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2012-08-16
Quantum computers promise to reach computation speeds far beyond that of today's computers. As they would use quantum effects, however, they would also be susceptible to external interferences. Information flow into and out of the system is a critical point. Researchers from KIT with partners from Grenoble and Strasbourg have now read out the quantum state of an atom directly by using electrodes. In the Nature journal, it is reported about the stable interface between classical and quantum world. (DOI: 10.1038/nature11341)
"Normally, every contact with the outer world ...
2012-08-16
Chapel Hill, NC – Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.
In chronic Graft vs. Host Disease (GVHD), the differences between the donor bone marrow cells and the recipient's body often cause these immune cells to recognize the recipient's body tissues as foreign and the newly transplanted cells attack the transplant recipient's body. Symptoms can range from dry eyes and ...
2012-08-16
While your DNA is unique, it also tells the tale of your family line. It carries the genetic history of your ancestors down through the generations. Now, says a Tel Aviv University researcher, it's also possible to use it as a map to your family's past.
Prof. Eran Halperin of TAU's Blavatnik School of Computer Science and Department of Molecular Microbiology and Biotechnology, along with a group of researchers from University of California, Los Angeles, are giving new meaning to the term "genetic mapping." Using a probabilistic model of genetic traits for every coordinate ...
2012-08-16
CHAMPAIGN, Ill. — Birds of a feather flock together and – according to a new analysis – so do their lice.
A study of the genetic heritage of avian feather lice indicates that their louse ancestors first colonized a particular group of birds (ducks or songbirds, for example) and then "radiated" to different habitats on those birds – to the wings or heads, for instance, where they evolved into different species. This finding surprised the researchers because wing lice from many types of birds look more similar to one another than they do to head or body lice living on the ...
2012-08-16
New Rochelle, NY, August 16, 2012—Every year tribal gaming generates billions of dollars in revenue, creates tens of thousands of jobs, and boosts the economies of many Native American communities. In the state of California alone, tribal gaming has brought in $7.5 billion annually. However, because of the aggressive movement to legalize Internet gambling, which effectively would give states the power to regulate and tax online gambling even on reservations, the financial success of these communities could change. In "Native American Off-Reservation Gaming," an expert roundtable ...
2012-08-16
After a surgeon stitches up a patient's abdomen, costly complications -- some life-threatening -- can occur. To cut down on these postoperative problems, Johns Hopkins undergraduates have invented a disposable suturing tool to guide the placement of stitches and guard against the accidental puncture of internal organs.
The student inventors have described their device, called FastStitch, as a cross between a pliers and a hole-puncher. Although the device is still in the prototype stage, the FastStitch team has already received recognition and raised more than $80,000 ...
2012-08-16
Ancient pollen and charcoal preserved in deeply buried sediments in Egypt's Nile Delta document the region's ancient droughts and fires, including a huge drought 4,200 years ago associated with the demise of Egypt's Old Kingdom, the era known as the pyramid-building time.
"Humans have a long history of having to deal with climate change," said Christopher Bernhardt, a researcher with the U.S. Geological Survey. "Along with other research, this study geologically reveals that the evolution of societies is sometimes tied to climate variability at all scales – whether decadal ...
2012-08-16
Lounging on a sofa while watching a 3D movie is an exquisite pleasure for many film fans. Be that as it may, those nettlesome 3D glasses might diminish the fun somewhat. That's why television manufacturers are working on displays that can recreate the spellbinding magic of three-dimensional television images – without the glasses. Though prototypes of these TV screens already exist, consumers will not have to wait much longer for the market introduction of these autostereoscopic displays. Neverthe-less, the content might be a bit problematic: The 3D movies currently available ...
2012-08-16
Fairfax, Va.--The popular spice turmeric packs more than just flavor — it shows promise in fighting devastating viruses, Mason researchers recently discovered.
Curcumin, found in turmeric, stopped the potentially deadly Rift Valley Fever virus from multiplying in infected cells, says Aarthi Narayanan, lead investigator on the new study and a research assistant professor with Mason's National Center for Biodefense and Infectious Diseases.
Mosquito-borne Rift Valley Fever virus (RVF) is an acute, fever-causing virus that affects domestic animals such as cattle, sheep ...
2012-08-16
Everyone knows the adage: "If something sounds too good to be true, then it probably is." Why, then, do some people fall for scams and why are older folks especially prone to being duped?
An answer, it seems, is because a specific area of the brain has deteriorated or is damaged, according to researchers at the University of Iowa. By examining patients with various forms of brain damage, the researchers report they've pinpointed the precise location in the human brain, called the ventromedial prefrontal cortex, that controls belief and doubt, and which explains why some ...
LAST 30 PRESS RELEASES:
[Press-News.org] Enzalutamide adds 5 months survival in late-stage prostate cancer
Major clinical trial shows survival benefit
